You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic breast cancer (MBC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer (MBC) Trial in Nanjing, Shanghai (Paclitaxel Polymeric Micelles for Injection, Eribulin Mesilate

Recruiting
  • Metastatic Breast Cancer (MBC)
  • Paclitaxel Polymeric Micelles for Injection
  • +5 more
  • Nanjing, Jiangsu, China
  • +2 more
Nov 21, 2023

Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)

Recruiting
  • Metastatic Breast Cancer
  • CellSearch Circulating Tumor Cells
  • Rochester, Minnesota
  • +1 more
Dec 21, 2022

Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)

Active, not recruiting
  • Metastatic Breast Cancer (MBC)
  • Basking Ridge, New Jersey
  • +4 more
Oct 31, 2022

Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Biyun Wang, MD
    Apr 5, 2023

    Breast Cancer Stage IV Trial in Irvine (Gallium-68)

    Recruiting
    • Breast Cancer Stage IV
    • Irvine, California
      Hoag Memorial Hospital Presbyterian
    May 26, 2023

    Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)

    Recruiting
    • Metastatic Breast Cancer
    • Ixabepilone Injection
    • Aalst, Belgium
    • +11 more
    Nov 28, 2022

    Breast Cancer Trial in Spain (Olaparib)

    Terminated
    • Breast Cancer
    • Barcelona, Spain
    • +7 more
    Jan 18, 2023

    Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

    Terminated
    • Breast Neoplasms
    • Malignant Tumor of the Breast
    • Multiple Locations, Texas
      19 Sites
    Nov 29, 2022

    Invasive Breast Cancer, Metastatic Breast Cancer, HR-Positive Breast Cancer Trial in United States (Pembrolizumab, Sacituzumab

    Recruiting
    • Invasive Breast Cancer
    • +3 more
    • Atlanta, Georgia
    • +7 more
    Nov 14, 2022

    Metastatic Breast Cancer Trial in United States (Orteronel)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • New Haven, Connecticut
    • +9 more
    Jun 8, 2022

    Fatigue, Metastatic Breast Carcinoma Trial in Pittsburgh (Apollo Armband)

    Recruiting
    • Fatigue
    • Metastatic Breast Carcinoma
    • Apollo Armband
    • Pittsburgh, Pennsylvania
      Magee Womens Hospital
    Jan 27, 2022

    ER+, HER2-, Metastatic Breast Cancer Trial in China (AZD9833, AZD9833 with palbociclib, AZD9833 with everolimus)

    Recruiting
    • ER+, HER2-, Metastatic Breast Cancer
    • Beijing, China
    • +5 more
    Jan 13, 2023

    Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)

    Recruiting
    • Breast Cancer
    • Endocrine Therapy and a CDK 4/6 inhibitor
    • Baltimore, Maryland
      Johns Hopkins University
    Jul 18, 2022

    Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and

    Not yet recruiting
    • Invasive Mammary Carcinoma
    • Metastatic Breast Cancer
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Jan 11, 2023

    A Real-world Study of Inetetamab for First-line Treatment of MBC

    Not yet recruiting
    • Breast Cancer
    • Real-world Study
    • (no location specified)
    Aug 6, 2023

    Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Boston (Cessation of anti-HER2 treatment)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Cessation of anti-HER2 treatment
    • Boston, Massachusetts
    • +1 more
    Feb 9, 2023

    Non-invasive Dual-Pet Information in Subtype of Metastatic

    Recruiting
    • Breast Cancer
    • biopsy or surgical pathology in metastases
    • 68Ga-HER2 affibody,18F-FDG, 18F-FES
    • Shanghai, Shanghai, China
      Shanghai Cancer Center Institutional Review Board
    Apr 19, 2022

    Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Spain (Trastuzumab deruxtecan)

    Not yet recruiting
    • Locally Advanced Breast Cancer
    • Metastatic Breast Cancer
    • Trastuzumab deruxtecan
    • Cádiz, Andalucía, Spain
    • +18 more
    Feb 24, 2023

    Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

    Recruiting
    • Premenopausal Breast Cancer
    • +2 more
    • Taipei City, Taiwan
      Department of Oncology, National Taiwan University Hospital
    Feb 7, 2023

    Tolerability Outcomes of Alpelisib in Real-world

    Recruiting
    • Breast Cancer
    • alpelisib plus fulvestrant
    • Mumbai, Maharashtra, India
    • +3 more
    Jun 8, 2022

    Metastatic Breast Cancer Trial in United States (Paclitaxel+Reparixin)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • Scottsdale, Arizona
    • +4 more
    Sep 23, 2021

    CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Different treatment regimens following progression on CDK4/6 inhibitors.
    • (no location specified)
    Sep 5, 2023

    Breast Tumors Trial in Spain (No intervention)

    Recruiting
    • Breast Neoplasms
    • No intervention
    • Elche, Alicante, Spain
    • +39 more
    Jan 20, 2023

    Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

    Active, not recruiting
    • Breast Cancer Metastatic
    • Los Angeles, California
    • +24 more
    Aug 10, 2022

    Metastatic Breast Cancer Trial in Italy (Eribulin Mesylate, Capecitabine)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Brescia, Italy
    • +24 more
    Apr 18, 2023